MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Synucleinopathies"

  • 2025 International Congress

    Preliminary Results From an Italian Multicentric Study on Inherited Synaptopathies Characterized by Movement Disorders and Epilepsy

    L. Pollini, S. Galosi, F. Nardecchia, M. Mastrangelo, M. Bologna (Rome, Italy)

    Objective: To present the preliminary results of an Italian multicentric study on inherited synaptopathies Background: Inherited synaptopathies are rare genetic disorders characterized by complex and…
  • 2025 International Congress

    Proactive Brain Health Alliance Serving Those at Risk for Neurodegenerative Disease

    A. Mitchell, P. Mahant, S. Winter, K. Merkel (Phoenix, USA)

    Objective: Research advancements enable earlier identification of neurodegenerative disease risk via prodromal symptoms and genetic and biomarker testing. Those in the “space between” risk and…
  • 2025 International Congress

    Parkinson’s Progression Markers Initiative (PPMI): A Biomarker Engine for Therapeutic Development for PD and Related Synucleinopathies

    B. Mcmahon, A. Videnovic, A. Siderowf, B. Mollenhauer, C. Tanner, C. Coffey, C. Stanley, D. Weintraub, D. Galasko, E. Flagg, E. Brown, K. Merchant, K. Kieburtz, K. Poston, K. Marek, K. Fabrizio, L. Chahine, M. Kuhl, M. Frasier, R. Dobkin, R. Alcalay, S. Chowdury, T. Simuni, T. Foroud, T. Sherer, T. Tropea (Boston, USA)

    Objective: PPMI is a longitudinal, observational study investigating clinical, imaging, genetic and biofluid biomarkers to accelerate therapeutic development for Parkinson’s disease (PD) and related synucleinopathies…
  • 2025 International Congress

    Contribution of β-band functional connectivity to the α-synuclein propagation in early-stage Parkinson’s Disease: insights from the analysis of brain network properties

    M. Conti, A. Guerra, V. Ferrari, V. D'Onofrio, G. Sancesario, M. Pierantozzi, NB. Mercuri, A. Antonini, T. Schirinzi, A. Stefani (Rome, Italy)

    Objective: To investigate the relationship between CSF α-synuclein levels and EEG-based network properties, aiming to clarify their role in PD pathophysiology. Background: Parkinson’s disease (PD)…
  • 2025 International Congress

    Assessment of the impact of the diabetic features hyperglycemia and insulin resistance on fibril induced synucleinopathy

    S. Nelson, G. Barajas, A. Cole-Strauss, M. Kubik, C. Kemp, C. Sortwell, J. Patterson (Grand Rapids, USA)

    Objective: Investigate the effects of diabetic features on the induction and severity of synucleinopathies such as Parkinson’s disease (PD). Background: Type 2 diabetes (T2D) is…
  • 2025 International Congress

    Disease Modifying Potential of a Novel ROCK Inhibitor in Rodent Models of Synucleinopathy

    M. Kubik, J. Mackeigan, A. Stoll, J. Patterson, J. Lipton, K. Steece-Collier, A. Cole-Strauss, C. Kemp, J. Howe, K. Miller, F. Manfredsson, S. Celano, K. Luk, C. Sortwell (Grand Rapids, USA)

    Objective: Evaluate the impact of a novel Rho-associated kinase (ROCK) inhibitor on alpha-synuclein (a-syn) pathology, neuroinflammation, and dopamine neurodegeneration in the AAV-a-syn overexpression and a-syn…
  • 2025 International Congress

    Sleep-wake Alterations are Associated with a Decreased DTI-ALPS, a Marker of Perivascular Glymphatic Functioning, in Patients with Isolated REM Sleep Behavior Disorder

    I. Roura, J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, C. Garcia-Vicente, N. Bargalló, M. Serradell, C. Gaig, G. Mayà, A. Montini, J. Madrir, M. Rol, A. Adan, C. Junqué, A. Iranzo, B. Segura (Barcelona, Spain)

    Objective: We aimed to explore circadian disruption in iRBD and its association with the Diffusion Tensor Imaging- ALong the Perivascular Space (DTI-ALPS) index, a proxy…
  • 2025 International Congress

    Epigenome-wide and gene-targeted epigenetic profile of isolated REM Sleep Behaviour Disorder: a clinico-molecular study

    L. Baldelli, C. Pirazzini, L. Sambati, F. Ravaioli, F. Di Laudo, D. Gentilini, P. Guaraldi, C. Franceschi, P. Cortelli, P. Garagnani, G. Calandra-Buonaura, MG. Bacalini, F. Provini (Bologna, Italy)

    Objective: Comprehensively characterize the epigenetic profile of isolated REM Sleep Behaviour Disorder (iRBD) using genome-wide and gene-targeted approaches, linking it to clinical measures and  phenoconversion.…
  • 2025 International Congress

    Paradoxical Association of Kinetics of α-Synuclein Seed Amplification 24-hrs Assay and Clinico-Pathological Markers of Parkinson’s disease

    SM. Fereshtehnejad, Y. Zeighami, C. Marras (TORONTO, Canada)

    Objective: To investigate the association between baseline α-synuclein seed amplification assay (SAA) parameters and clinical and biomarker features of Parkinson’s disease (PD) at baseline and…
  • 2025 International Congress

    Real world application of alpha-synuclein skin biopsy in the diagnosis of synucleinopathies at a tertiary care center

    C. Yu, C. Cooper (Nashville, USA)

    Objective: The goal of this study is to review the real-world application of alpha-synuclein skin biopsy at a tertiary care center. Background: Synucleniopathies including Parkinson’s…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley